CAMBRIDGE, Mass.--(BUSINESS WIRE)--Be Biopharma, Inc. (“Be Bio”), a company pioneering the discovery and development of Engineered B Cell Medicines (BeCMs), will present preclinical research today ...
Gene editing platforms like CRISPR-Cas9 that rely on nuclease activity introduce effective modifications, however, they arise from double strand DNA breaks (DSBs) introduced by the nuclease that can ...
Precise Bio 3D printed a cornea implant from living human cells, and the Rambam Health Care Campus successfully transplanted ...
The Nature Index 2025 Research Leaders — previously known as Annual Tables — reveal the leading institutions and countries/territories in the natural and health sciences, according to their output in ...
Researchers at the Toyota Research Institute (TRI) in Los Altos, Calif. have released a pair of papers describing a technique for incorporating precise engineering constraints into a generative ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results